CYTK Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into CYTK

Also see:
• CYTK stock yearly return 2014
• CYTK stock yearly return 2015
• CYTK stock yearly return 2016
• CYTK stock yearly return 2017
• CYTK stock yearly return 2018
• CYTK stock yearly return 2019
• CYTK stock yearly return 2020
• CYTK stock yearly return 2021
• CYTK stock yearly return 2022
• CYTK stock yearly return 2023
• CYTK YTD return

Compare CYTK average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	04/16/2014
End date:	04/15/2024
Start price/share:	$9.07
End price/share:	$68.00
Dividends collected/share:	$0.00
Total return:	649.72%
CYTK Average Annual Return:	22.30%
Starting investment:	$10,000.00
Ending investment:	$74,945.16
Years:	10.01

CYTK average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor. The CYTK average annual return 10 years is shown above.

The Average Annual Return on the CYTK average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CYTK average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CYTK average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free CYTK Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Cytokinetics (CYTK) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

DARE Average Annual Return
DAWN Average Annual Return
DCGO Average Annual Return
DCPH Average Annual Return
DCTH Average Annual Return
DERM Average Annual Return
DGX Average Annual Return
DHR Average Annual Return
DMTK Average Annual Return
DNLI Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Cytokinetics (CYTK) ranks in the top 25% of all stocks whose returns we have reviewed.

What has the average annual return been for CYTK over the past ten years?

✔️Accepted answer: The ten year CYTK average annual return has been 22.30%.

What start date was used in your CYTK average annual return calculation?

✔️Accepted answer: The start date was 04/16/2014.

What end date was used in your CYTK average annual return calculation?

✔️Accepted answer: The end date was 04/15/2024.

If I had invested $10,000 into CYTK ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 04/15/2024, you would have $74,945.16.

What does that work out to on a total return basis?

✔️Accepted answer: The CYTK ten year total return ending 04/15/2024 works out to 649.72%.

CYTK Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved